J&J settles New York opioid lawsuits for $230M

Johnson & Johnson reached a $230 million settlement with the state of New York for its role in the opioid crisis, state Attorney General Letitia James The agreement "acknowledges Johnson & Johnson’s exit from the opioid business nationally."J&J may also be required to pay up to $30 million more during the next 12 months if a measure creating an opioid settlement fund becomes law, according to the state AG's press release.

"Johnson & Johnson helped fuel this fire, but today they’re committing to leaving the opioid business — not only in New York, but across the entire country. Opioids will no longer be manufactured or sold in the United States by J&J," she added.Our goal is to create a safe and engaging place for users to connect over interests and passions.

But, doesn’t that hurt folks who rely on Opioids for pain?

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Johnson & Johnson Settles New York Opioid Case for $230 MillionJohnson & Johnson agreed to pay $230 million to New York state to resolve an opioid lawsuit. The company agreed to stop selling opioids nationwide. Have they ever been sued for that no-tears baby shampoo that would always sting our eyes and make them water? What about the people that really need them? For your Business advertising❤️❤️❤️fiverr socialmediamarketing facebookads facebookmarketing imstagramads adscampaign
Source: WSJ - 🏆 98. / 63 Read more »